XD9E:XETRA:XETRA-Xtrackers MSCI USA UCITS ETF 2C - EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 123.925

Change

+0.83 (+0.67)%

Market Cap

USD 0.27B

Volume

698.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.52 (+0.97%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.22 (+1.27%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.50%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.33 (+1.14%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.39 (+1.52%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.33%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

+1.02 (+0.72%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.22 (+0.42%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.19 (+1.11%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.92 (+1.13%)

USD 80.38B

ETFs Containing XD9E:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.74% 46% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.74% 46% F 45% F
Trailing 12 Months  
Capital Gain 21.26% 75% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.26% 74% C 73% C
Trailing 5 Years  
Capital Gain 74.87% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.87% 84% B 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 14.50% 80% B- 78% C+
Dividend Return 14.50% 79% B- 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.83% 20% F 33% F
Risk Adjusted Return 73.09% 63% D 68% D+
Market Capitalization 0.27B 51% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.